University of Minnesota
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT01738607
The primary aim of this study was to compare the effects of supplementation with one of three dietary fibers (gum arabic, carboxy-methylcellulose, or psyllium) or a placebo on fecal incontinence (FI), symptom intolerance, and quality of life in community-living individuals who have incontinence of loose or liquid feces. A secondary aim was to explore the possible mechanism(s) underlying the supplements' efficacy (i.e., improvements in stool consistency, water-holding capacity or gel formation).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55455, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Gum acacia dietary fiber
Other names: Gum acacia
dietary fiber
the date and time of an incontinence episode was reported and the ratio of the number of incontinence episodes to total stools daily was calculated
The amount of GI symptoms reported were flatus, belching, bloating, abdominal cramping, nausea, a feeling of fullness, and stomach upset using a categorical scale. Number of times of flatus was also reported.
The amount of two obfuscating symptoms were also reported. headache and sleepiness.
How upsetting/bothersome the symptoms were were also reported.
The Fecal Incontinence Quality of Life tool (FIQL) was used; Rockwood, T.H. et al. Diseases of the Colon & Rectum. 2000;43(1):9-16.
Measure was done on stools of 52 randomly selected subjects (13 from each group) Established method of Wenzl, H. et al. Gastroenterology. 1995;108(6):1729-38 used.
Measure was done on stools of 52 randomly selected subjects (13 from each group); Established method of Fischer, M.H. et al.Carbohydrate Research 2004;339(11): 2009-2017.
Measured in composites of all stools from baseline and supplement periods and non-frozen stools
Established method of Theander O, et al. J AOAC Int. 1995;78(4):1030-44 used.
reported by fractions on supplement intake form and return of unconsumed portion was assessed by study team
subjects self-reported greatest amount of soiling (from soling of tissue between buttocks to shoes or floor)
collected stools were weighed and freeze-dried to constant weight; percentage of water content was calculated from these values
the Stool Consistency Classification System used was shown to be valid and reliable
written record of all food and drink consumed
subjects checked whether the drank required amount of additional fluid and wrote the date and time of drinking
subjects indicated number of absorbent products that were soiled on stool diary and and saved and returned them to be assessed by study team
reported on stool diary daily with reason for not collecting
date and time a stool color change was observed after swallowing a capsule with a decoy or marker dose of a food dye; date and time capsule was taken was also reported
nested experiment of in vitro degradation of each dietary fiber by stools of subjects using established procedure reported in Bliss, D.Z. et al. Nurs. Res. 2001, 50, 203-213.
established method of Theander O. et al. J AOAC Int. 1995;78(4):1030-44 used.
data obtained by semi-structured interview
data obtained by semi-structured interview
University of Minnesota
Other
The Impact of Fiber Fermentation on Fecal Incontinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04806386
Colonic Diseases, Colonic Diseases, Functional
Boston, Massachusetts, United States
View Trial DetailsNCT00213317
Colonic Diseases, Colonic Diseases, Functional
Rouen, France
View Trial DetailsNCT01786304
Digestive System Diseases, Fecal Incontinence
Rouen, Normandy, France
View Trial DetailsNCT05773742
Constipation, Digestive System Diseases
Aarhus, Denmark
View Trial Details